Krsnaa Diagnostics Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 140 Cr | 295 Cr | 453 Cr | 620 Cr | 170 Cr | 357 Cr | 175 Cr | 186 Cr | 193 Cr | 206 Cr | 181 Cr | 193 Cr |
| Operating expenses (approx.) | 104 Cr | 223 Cr | 340 Cr | 459 Cr | 120 Cr | 253 Cr | 129 Cr | 129 Cr | 138 Cr | 143 Cr | 131 Cr | 106 Cr |
| EBITDA | 36 Cr | 72 Cr | 113 Cr | 161 Cr | 50 Cr | 104 Cr | 45 Cr | 57 Cr | 55 Cr | 63 Cr | 50 Cr | 86 Cr |
| OPM % | 25.5% | 24.2% | 24.9% | 26.0% | 29.4% | 29.2% | 25.8% | 30.8% | 28.7% | 30.7% | 27.7% | 44.8% |
| Other income | 4 Cr | 8 Cr | 12 Cr | 17 Cr | 7 Cr | 12 Cr | 9 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 31 Cr |
| Interest | 2 Cr | 5 Cr | 9 Cr | 16 Cr | 5 Cr | 12 Cr | 6 Cr | 7 Cr | 6 Cr | 8 Cr | 8 Cr | 12 Cr |
| Depreciation | 16 Cr | 35 Cr | 56 Cr | 75 Cr | 21 Cr | 44 Cr | 23 Cr | 22 Cr | 22 Cr | 24 Cr | 23 Cr | 23 Cr |
| Profit before tax | 18 Cr | 31 Cr | 47 Cr | 70 Cr | 23 Cr | 49 Cr | 25 Cr | 29 Cr | 27 Cr | 32 Cr | 20 Cr | 52 Cr |
| Tax % | 18.2% | 19.7% | 19.6% | 18.8% | 22.8% | 22.8% | 23.8% | 27.7% | 25.2% | 24.1% | 22.5% | 19.3% |
| Net profit | 15 Cr | 25 Cr | 38 Cr | 57 Cr | 18 Cr | 38 Cr | 19 Cr | 21 Cr | 21 Cr | 24 Cr | 15 Cr | 42 Cr |
| EPS (₹) | ₹4.66 | ₹8.01 | ₹12.10 | ₹17.90 | ₹5.55 | ₹11.62 | ₹6.01 | ₹6.40 | ₹6.35 | ₹7.38 | ₹4.72 | ₹12.86 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 455 Cr | 487 Cr | 620 Cr | 717 Cr | 773 Cr | Sign in for TTM |
| Operating expenses (approx.) | 309 Cr | 365 Cr | 475 Cr | 501 Cr | 518 Cr | Sign in for TTM |
| EBITDA | 146 Cr | 122 Cr | 144 Cr | 216 Cr | 255 Cr | Sign in for TTM |
| OPM % | 32.1% | 25.1% | 23.3% | 30.1% | 33.0% | Sign in for TTM |
| Other income | 15 Cr | 19 Cr | 17 Cr | 26 Cr | 43 Cr | Sign in for TTM |
| Interest | 18 Cr | 8 Cr | 16 Cr | 25 Cr | 34 Cr | Sign in for TTM |
| Depreciation | 41 Cr | 54 Cr | 75 Cr | 88 Cr | 90 Cr | Sign in for TTM |
| Profit before tax | 87 Cr | 80 Cr | 70 Cr | 103 Cr | 130 Cr | Sign in for TTM |
| Tax % | 20.9% | 22.6% | 18.8% | 24.4% | 22.2% | Sign in for TTM |
| Net profit | 68 Cr | 62 Cr | 57 Cr | 78 Cr | 101 Cr | Sign in for TTM |
| EPS (₹) | ₹22.89 | ₹19.78 | ₹17.90 | ₹24.04 | ₹31.30 | Sign in for TTM |
| Dividend payout % | 0.0% | 12.6% | 15.2% | 10.4% | 8.8% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 16 Cr | 16 Cr | 16 Cr | 16 Cr | 16 Cr |
| Reserves | 669 Cr | 723 Cr | 794 Cr | 867 Cr | 964 Cr |
| Borrowings | — | 32 Cr | 160 Cr | 156 Cr | 66 Cr |
| Other liabilities | — | 139 Cr | 202 Cr | 242 Cr | 777 Cr |
| Total liabilities | — | 910 Cr | 1,172 Cr | 1,282 Cr | 1,824 Cr |
| Fixed assets (net) | — | 468 Cr | 645 Cr | 667 Cr | 652 Cr |
| CWIP | — | 25 Cr | 10 Cr | 3 Cr | 208 Cr |
| Investments | — | 0.29 Cr | 0.29 Cr | 32 Cr | 57 Cr |
| Other assets | — | 226 Cr | 421 Cr | 414 Cr | 738 Cr |
| Total assets | — | 910 Cr | 1,172 Cr | 1,282 Cr | 1,824 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 128 Cr | 76 Cr | 24 Cr | 87 Cr | 143 Cr |
| Cash from investing | -241 Cr | -109 Cr | -129 Cr | -100 Cr | -396 Cr |
| Cash from financing | 176 Cr | -33 Cr | 84 Cr | 14 Cr | 279 Cr |
| Net cash flow | 64 Cr | -66 Cr | -20 Cr | 1 Cr | 26 Cr |
| Free cash flow (OCF − Capex) | -4 Cr | -65 Cr | -170 Cr | -39 Cr | -76 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 15.3% | 8.9% | 7.2% | 12.3% | 15.7% |
| ROE % | 10.0% | 8.4% | 7.0% | 8.8% | 10.3% |
| Debtor days | — | 55 | 104 | — | — |
| Inventory days | — | 123 | 93 | 63 | 54 |
| Days payable | — | 305 | 213 | — | — |
| Cash conversion cycle | — | -127 | -17 | 63 | 54 |
| Debt / equity | — | 0.04 | 0.20 | 0.18 | 0.07 |
| Current ratio | — | 2.28 | 1.50 | 1.36 | 2.68 |
| Net debt / EBITDA | 0.00 | 0.08 | 1.09 | 0.71 | 0.14 |
Compare with peers
Loading peers…